Aktis Oncology prices upsized US IPO at $18 per share - Reuters

Reuters | Jan. 8, 2026, 9:20 p.m. | Original
Aktis Oncology prices upsized US IPO at $18 per share Reuters
Oil rises as concerns about supply disruptions in Venezuela, Iran increase - Reuters J&J strikes deal with US government to cut drug prices, gain tariff exemptions - Reuters